All Stories

  1. The dawn of a new era of therapies in systemic lupus erythematosus

    Article • Rheumatology and Immunology Research, December 2020, De Gruyter

    Dr chi chiu mok

  2. Metabolic syndrome and systemic lupus erythematosus: the connection

    Article • Expert Review of Clinical Immunology, May 2019, Taylor & Francis

    Dr chi chiu mok

  3. Identification of Low‐Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays

    Article • Arthritis & Rheumatology, April 2019, Wiley

    Dr chi chiu mok

  4. The Hong Kong Society of Rheumatology Biologics Registry: Updated Report (Nov 2018)

    Article • Hong Kong Bulletin on Rheumatic Diseases, December 2018, De Gruyter

    Dr chi chiu mok

  5. Is Treat-to-target in Lupus Nephritis Realistic in Clinical Practice?

    Article • Current Rheumatology Reviews, December 2018, Bentham Science Publishers

    Dr chi chiu mok

  6. The Jakinibs in systemic lupus erythematosus: progress and prospects

    Article • Expert Opinion on Investigational Drugs, November 2018, Taylor & Francis

    Dr chi chiu mok

  7. Herpes zoster vaccination in systemic lupus erythematosus: the current status

    Article • Human Vaccines & Immunotherapeutics, August 2018, Taylor & Francis

    Dr chi chiu mok

  8. The Hong Kong Society of Rheumatology Biologics Registry: Updated Report (May 2018)

    Article • Hong Kong Bulletin on Rheumatic Diseases, July 2018, De Gruyter

    Dr chi chiu mok

  9. The Hong Kong Society of Rheumatology Biologics Registry: Updated Report (November 2017)

    Article • Hong Kong Bulletin on Rheumatic Diseases, December 2017, De Gruyter

    Dr chi chiu mok

  10. EULAR recommendations for the management of rheumatoid arthritis: what is new in 2017 and its applicability in our local setting

    Article • Hong Kong Bulletin on Rheumatic Diseases, November 2017, De Gruyter

    Dr chi chiu mok

  11. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort

    Article • Lupus, October 2017, SAGE Publications

    Dr chi chiu mok

  12. Intercorrelation between MRI disease activity scores of the sacroiliac joints and the spine, and clinical disease activity indices in patients with axial spondyloarthritis

    Article • Reports in Medical Imaging, September 2017, Dove Medical Press

    Dr chi chiu mok

  13. Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art

    Article • Expert Review of Clinical Immunology, May 2017, Taylor & Francis

    Dr chi chiu mok

  14. Dissonance between physicians’ and patients’ perspectives on managing impaired morning function in Asian patients with rheumatoid arthritis

    Article • Hong Kong Bulletin on Rheumatic Diseases, January 2017, De Gruyter

    Dr chi chiu mok

  15. The Hong Kong Society of Rheumatology Biologics Registry: Updated Report (December 2016)

    Article • Hong Kong Bulletin on Rheumatic Diseases, December 2016, De Gruyter

    Dr chi chiu mok

  16. Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus

    Article • Lupus, November 2016, SAGE Publications

    Dr chi chiu mok

  17. The Hong Kong Society of Rheumatology Biologics Registry: Updated Report (May 2016)

    Article • Hong Kong Bulletin on Rheumatic Diseases, January 2016, De Gruyter

    Dr chi chiu mok

  18. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up

    Article • Annals of the Rheumatic Diseases, December 2014, BMJ

    Dr chi chiu mok

  19. Current role of rituximab in systemic lupus erythematosus

    Article • International Journal of Rheumatic Diseases, December 2014, Wiley

    Dr chi chiu mok

  20. SAT0020 Cross Cultural Adaptation and Validation of Lupuspro in Southern Chinese Patients with Systemic Lupus Erythematosus: Table 1.

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Dr chi chiu mok

  21. Update on B-cell targeted therapies for systemic lupus erythematosus

    Article • Expert Opinion on Biological Therapy, March 2014, Informa Healthcare

    Dr chi chiu mok

  22. Emerging biological therapies for systemic lupus erythematosus

    Article • Expert Opinion on Emerging Drugs, March 2014, Informa Healthcare

    Dr chi chiu mok

  23. Neuro-ophthalmologic manifestations of systemic lupus erythematosus: a systematic review

    Article • International Journal of Rheumatic Diseases, March 2014, Wiley

    Dr chi chiu mok

  24. Suicidal ideation in patients with systemic lupus erythematosus: incidence and risk factors

    Article • Rheumatology, December 2013, Oxford University Press (OUP)

    Dr chi chiu mok

  25. Overview of lupus nephritis management guidelines and perspective from Asia

    Article • Nephrology, December 2013, Wiley

    Dr chi chiu mok

  26. Overview of lupus nephritis management guidelines and perspective from Asia

    Article • International Journal of Rheumatic Diseases, October 2013, Wiley

    Dr chi chiu mok

  27. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study

    Article • Lupus, August 2013, SAGE Publications

    Dr chi chiu mok

  28. Development of systemic lupus erythematosus in a male-to-female transsexual: the role of sex hormones revisited

    Article • Lupus, July 2013, SAGE Publications

    Dr chi chiu mok

  29. Effect of Renal Disease on the Standardized Mortality Ratio and Life Expectancy of Patients With Systemic Lupus Erythematosus

    Article • Arthritis & Rheumatism, July 2013, Wiley

    Dr chi chiu mok

  30. Prevalence of the Antiphospholipid Syndrome and Its Effect on Survival in 679 Chinese Patients With Systemic Lupus Erythematosus

    Article • Medicine, July 2013, Wolters Kluwer Health

    Dr chi chiu mok

  31. AB0390 Suicidal ideation in patients with systemic lupus erythematosus: prevalence and risk factors

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr chi chiu mok

  32. THU0299 Factors Associated with Long-Term Renal Function Deterioration in Lupus Nephritis Treated Initially with Combined Prednisolone and Mycophenolate Mofetil (MMF) or Tacrolimus (TAC)

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr chi chiu mok

  33. THU0300 Serum Mercury Level and Disease Activity of Systemic Lupus Erythematosus (SLE): A Case-Control Study

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr chi chiu mok

  34. THU0301 Effect of Renal Disease on Standardized Mortality Ratio and Life Expectancy of Patients with Systemic Lupus Erythematosus

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr chi chiu mok

  35. THU0302 Hepcidin, Interleukin-6 and Anemia of Chronic Inflammation in Systemic Lupus Erythematosus (SLE)

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr chi chiu mok

  36. Vitamin D and systemic lupus erythematosus: an update

    Article • Expert Review of Clinical Immunology, May 2013, Taylor & Francis

    Dr chi chiu mok

  37. High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus

    Article • Arthritis Care & Research, February 2013, Wiley

    Dr chi chiu mok

  38. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus

    Article • Arthritis & Rheumatism, December 2012, Wiley

    Dr chi chiu mok

  39. Glucocorticoid-Induced Avascular Bone Necrosis: Diagnosis and Management

    Article • The Open Orthopaedics Journal, October 2012, Bentham Science Publishers

    Dr chi chiu mok

  40. Abatacept for systemic lupus erythematosus: the outlook

    Article • Expert Opinion on Biological Therapy, September 2012, Informa Healthcare

    Dr chi chiu mok

  41. Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis—Should MMF Be Considered the Drug of Choice?

    Article • Clinical Journal of the American Society of Nephrology, August 2012, American Society of Nephrology

    Dr chi chiu mok, Dr Lai Senng Hooi, T M Chan, Brad Rovin

  42. Concurrent psychiatric disorders are associated with significantly poorer quality of life in patients with rheumatoid arthritis

    Article • Scandinavian Journal of Rheumatology, June 2012, Taylor & Francis

    Dr chi chiu mok

  43. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study

    Article • Annals of the Rheumatic Diseases, May 2012, BMJ

    Dr chi chiu mok

  44. Understanding lupus nephritis: diagnosis, management, and treatment options

    Article • International Journal of Women s Health, May 2012, Taylor & Francis

    Dr chi chiu mok

  45. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: Prevalence, incidence, clinical features, and mortality

    Article • Arthritis Care & Research, January 2012, Wiley

    Dr chi chiu mok

  46. Changes in Anthropometric Measures in Systemic Lupus Erythematosus

    Article • January 2012, Springer Science + Business Media

    Dr chi chiu mok

  47. The Outlook of Belimumab in the Treatment of Systemic Lupus Erythematosus

    Article • Journal of Developing Drugs, January 2012, OMICS Publishing Group

    Dr chi chiu mok

  48. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus

    Article • Rheumatology, November 2011, Oxford University Press (OUP)

    Dr chi chiu mok

  49. Association of CD247 with systemic lupus erythematosus in Asian populations

    Article • Lupus, October 2011, SAGE Publications

    Dr chi chiu mok, Dr Mo Yin Mok, Prof. Hai-Feng Pan, Dr Wilfred Hing Sang Wong

  50. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q

    Article • Lupus, October 2011, SAGE Publications

    Dr chi chiu mok

  51. Belimumab: the first US FDA approved biological therapy for systemic lupus erythematosus

    Article • International Journal of Clinical Rheumatology, August 2011, OMICS Publishing Group

    Dr chi chiu mok

  52. Moyamoya phenomenon in systemic lupus erythematosus

    Article • Rheumatology, July 2011, Oxford University Press (OUP)

    Dr chi chiu mok

  53. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis

    Article • Rheumatology, June 2011, Oxford University Press (OUP)

    Dr chi chiu mok

  54. Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: A randomized, double-blind, placebo-controlled trial

    Article • Arthritis Care & Research, May 2011, Wiley

    Dr chi chiu mok

  55. Association of a functional IRF7 variant with systemic lupus erythematosus

    Article • Arthritis & Rheumatism, February 2011, Wiley

    Dr chi chiu mok, Dr Mo Yin Mok

  56. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese

    Article • Lupus, December 2010, SAGE Publications

    Dr chi chiu mok

  57. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus

    Article • Translational Research, December 2010, Elsevier

    Dr chi chiu mok

  58. Authors’ Reply

    Article • Scandinavian Journal of Rheumatology, November 2010, Taylor & Francis

    Dr chi chiu mok

  59. Erythema elevatum diutinum in systemic lupus erythematosus

    Article • Rheumatology International, July 2010, Springer Science + Business Media

    Dr chi chiu mok

  60. Minimal mesangial lupus nephritis: a systematic review

    Article • Scandinavian Journal of Rheumatology, February 2010, Taylor & Francis

    Dr chi chiu mok

  61. Update on emerging drug therapies for systemic lupus erythematosus

    Article • Expert Opinion on Emerging Drugs, February 2010, Informa Healthcare

    Dr chi chiu mok

  62. Racial difference in the prognosis of lupus nephritis

    Article • Nephrology, February 2010, Wiley

    Dr chi chiu mok

  63. Venous thromboembolism in southern Chinese patients with systemic lupus erythematosus

    Article • Clinical Rheumatology, January 2010, Springer Science + Business Media

    Dr chi chiu mok

  64. Biomarkers for Lupus Nephritis: A Critical Appraisal

    Article • Journal of Biomedicine and Biotechnology, January 2010, Hindawi Publishing Corporation

    Dr chi chiu mok

  65. Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis

    Article • Lupus, October 2009, SAGE Publications

    Dr chi chiu mok

  66. Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine

    Article • Lupus, September 2009, SAGE Publications

    Dr chi chiu mok

  67. Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese

    Article • Genes & Immunity, April 2009, Springer Science + Business Media

    Dr chi chiu mok, Dr Mo Yin Mok, Dr Wilfred Hing Sang Wong

  68. Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma

    Article • Nature Reviews Nephrology, April 2009, Springer Science + Business Media

    Dr chi chiu mok

  69. Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese

    Article • Genes & Immunity, February 2009, Springer Science + Business Media

    Dr chi chiu mok, Dr Mo Yin Mok, Dr Wilfred Hing Sang Wong

  70. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus

    Article • Scandinavian Journal of Rheumatology, January 2009, Taylor & Francis

    Dr chi chiu mok

  71. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus

    Article • Scandinavian Journal of Rheumatology, January 2009, Taylor & Francis

    Dr chi chiu mok, Prof. Chun-Kwok WONG

  72. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2‐year prospective study

    Article • Scandinavian Journal of Rheumatology, January 2009, Taylor & Francis

    Dr chi chiu mok

  73. Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus

    Article • Lupus, December 2008, SAGE Publications

    Dr chi chiu mok

  74. Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus

    Article • Lupus, November 2008, SAGE Publications

    Dr chi chiu mok

  75. Bone mineral density and body composition in men with systemic lupus erythematosus: A case control study

    Article • Bone, August 2008, Elsevier

    Dr chi chiu mok

  76. Who should treat lupus nephritis: rheumatologists or nephrologists?

    Article • Nature Clinical Practice Nephrology, February 2008, Springer Science + Business Media

    Dr chi chiu mok

  77. Hormone replacement therapy in systemic lupus erythematosus

    Article • Nature Clinical Practice Rheumatology, January 2008, Springer Science + Business Media

    Dr chi chiu mok

  78. Rituximab for Refractory Rheumatoid Arthritis: A 24-Week Open-Label Prospective Study

    Article • The Open Rheumatology Journal, December 2007, Bentham Science Publishers

    Dr chi chiu mok

  79. Management of systemic lupus erythematosus in Chinese patients

    Article • Expert Review of Clinical Immunology, November 2007, Taylor & Francis

    Dr chi chiu mok

  80. Risk and Predictors of Arterial Thrombosis in Lupus and Non-Lupus Primary Glomerulonephritis

    Article • Medicine, July 2007, Wolters Kluwer Health

    Dr chi chiu mok

  81. Gastrointestinal Disease in Systemic Lupus Erythematosus

    Article • January 2007, Elsevier

    Dr chi chiu mok

  82. Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups

    Article • Lupus, January 2007, SAGE Publications

    Dr chi chiu mok

  83. Mycophenolate mofetil for non‐renal manifestations of systemic lupus erythematosus: a systematic review

    Article • Scandinavian Journal of Rheumatology, January 2007, Taylor & Francis

    Dr chi chiu mok

  84. Update on the current therapies of lupus nephritis

    Article • APLAR Journal of Rheumatology, December 2006, Wiley

    Dr chi chiu mok

  85. Emerging drug therapies for systemic lupus erythematosus

    Article • Expert Opinion on Emerging Drugs, October 2006, Informa Healthcare

    Dr chi chiu mok

  86. Therapeutic Options for Resistant Lupus Nephritis

    Article • Seminars in Arthritis and Rheumatism, October 2006, Elsevier

    Dr chi chiu mok

  87. Neuropsychiatric Damage in Southern Chinese Patients With Systemic Lupus Erythematosus

    Article • Medicine, July 2006, Wolters Kluwer Health

    Dr chi chiu mok

  88. Update on the Therapies of Severe Lupus Nephritis

    Article • Current Rheumatology Reviews, May 2006, Bentham Science Publishers

    Dr chi chiu mok

  89. Therapeutic advances in systemic lupus erythematosus

    Article • April 2006, Wiley

    Dr chi chiu mok

  90. Long-term Outcome of Diffuse Proliferative Lupus Glomerulonephritis Treated with Cyclophosphamide

    Article • The American Journal of Medicine, April 2006, Elsevier

    Dr chi chiu mok

  91. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine

    Article • Rheumatology, January 2006, Oxford University Press (OUP)

    Dr chi chiu mok

  92. Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus

    Article • Scandinavian Journal of Rheumatology, January 2006, Taylor & Francis

    Dr chi chiu mok

  93. Can survival of systemic lupus erythematosus be further improved?

    Article • December 2005, Wiley

    Dr chi chiu mok

  94. Mycophenolate mofetil for lupus related myelopathy

    Article • Annals of the Rheumatic Diseases, November 2005, BMJ

    Dr chi chiu mok

  95. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus

    Article • Lupus, October 2005, SAGE Publications

    Dr chi chiu mok

  96. Serositis related to systemic lupus erythematosus: prevalence and outcome

    Article • Lupus, October 2005, SAGE Publications

    Dr chi chiu mok

  97. Investigations and management of gastrointestinal and hepatic manifestations of systemic lupus erythematosus

    Article • Best Practice & Research Clinical Rheumatology, October 2005, Elsevier

    Dr chi chiu mok

  98. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study

    Article • Kidney International, August 2005, Elsevier

    Dr chi chiu mok

  99. Long-term Survival of Southern Chinese Patients With Systemic Lupus Erythematosus

    Article • Medicine, July 2005, Wolters Kluwer Health

    Dr chi chiu mok

  100. Treatment for lupus nephritis: A revisit. Review Article

    Article • Nephrology, April 2005, Wiley

    Dr chi chiu mok

  101. Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus

    Article • Lupus, February 2005, SAGE Publications

    Dr chi chiu mok

  102. Prognostic factors in lupus nephritis

    Article • Lupus, January 2005, SAGE Publications

    Dr chi chiu mok

  103. Raloxifene for postmenopausal women with systemic lupus erythematosus: A pilot randomized controlled study

    Article • Arthritis & Rheumatism, January 2005, Wiley

    Dr chi chiu mok

  104. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: A comparison of three ethnic groups

    Article • Arthritis & Rheumatism, January 2005, Wiley

    Dr chi chiu mok

  105. Cyclophosphamide for severe lupus nephritis: Where are we now?

    Article • Arthritis & Rheumatism, December 2004, Wiley

    Dr chi chiu mok

  106. Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus

    Article • The American Journal of Medicine, November 2004, Elsevier

    Dr chi chiu mok

  107. Lupus pneumonitis or severe acute respiratory syndrome?

    Article • Lupus, July 2004, SAGE Publications

    Dr chi chiu mok

  108. Shrinking central nervous system in systemic lupus erythematosus

    Article • Annals of the Rheumatic Diseases, May 2004, BMJ

    Dr chi chiu mok

  109. Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: an open-label trial

    Article • American Journal of Kidney Diseases, February 2004, Elsevier

    Dr chi chiu mok

  110. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis

    Article • Arthritis & Rheumatism, January 2004, Wiley

    Dr chi chiu mok

  111. Lupus in Hong Kong Chinese

    Article • Lupus, September 2003, SAGE Publications

    Dr chi chiu mok

  112. Treatment of severe proliferative lupus nephritis: the current state

    Article • Annals of the Rheumatic Diseases, September 2003, BMJ

    Dr chi chiu mok

  113. Mucormycosis in systemic lupus erythematosus

    Article • Seminars in Arthritis and Rheumatism, September 2003, Elsevier

    Dr chi chiu mok

  114. Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus

    Article • Neurology, July 2003, Wolters Kluwer Health

    Dr chi chiu mok

  115. Pathogenesis of systemic lupus erythematosus

    Article • Journal of Clinical Pathology, July 2003, BMJ

    Dr chi chiu mok

  116. Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study

    Article • The American Journal of Medicine, July 2003, Elsevier

    Dr chi chiu mok

  117. Scleroderma renal crisis sine scleroderma during pregnancy

    Article • Scandinavian Journal of Rheumatology, January 2003, Taylor & Francis

    Dr chi chiu mok

  118. Mycophenolate mofetil in lupus glomerulonephritis

    Article • American Journal of Kidney Diseases, September 2002, Elsevier

    Dr chi chiu mok

  119. Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine

    Article • Arthritis & Rheumatism, April 2002, Wiley

    Dr chi chiu mok

  120. Treatment of diffuse proliferative lupus glomerulonephritis: A comparison of two cyclophosphamide-containing regimens

    Article • American Journal of Kidney Diseases, August 2001, Elsevier

    Dr chi chiu mok

  121. Use of exogenous estrogens in systemic lupus erythematosus

    Article • Seminars in Arthritis and Rheumatism, June 2001, Elsevier

    Dr chi chiu mok

  122. Pregnancy in systemic lupus erythematosus

    Article • Postgraduate Medical Journal, March 2001, BMJ

    Dr chi chiu mok

  123. Profile of sex hormones in male patients with systemic lupus erythematosus

    Article • Lupus, May 2000, SAGE Publications

    Dr chi chiu mok

  124. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population

    Article • Rheumatology, April 2000, Oxford University Press (OUP)

    Dr chi chiu mok

  125. Lupus nephritis in southern Chinese patients: Clinicopathologic findings and long-term outcome

    Article • American Journal of Kidney Diseases, August 1999, Elsevier

    Dr chi chiu mok

  126. Ovarian failure and flares of systemic lupus erythematosus

    Article • Arthritis & Rheumatism, June 1999, Wiley

    Dr chi chiu mok

  127. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus

    Article • Lupus, March 1999, SAGE Publications

    Dr chi chiu mok

  128. Do flares of systemic lupus erythematosus decline after menopause?

    Article • Scandinavian Journal of Rheumatology, January 1999, Taylor & Francis

    Dr chi chiu mok

  129. Exacerbation of systemic lupus erythematosus by breast feeding

    Article • Lupus, October 1998, SAGE Publications

    Dr chi chiu mok

  130. Risk factors for avascular bone necrosis in systemic lupus erythematosus

    Article • Rheumatology, August 1998, Oxford University Press (OUP)

    Dr chi chiu mok

  131. Late onset systemic lupus erythematosus in southern Chinese

    Article • Annals of the Rheumatic Diseases, July 1998, BMJ

    Dr chi chiu mok

  132. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus

    Article • Arthritis & Rheumatism, June 1998, Wiley

    Dr chi chiu mok

  133. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy

    Article • Arthritis & Rheumatism, May 1998, Wiley

    Dr chi chiu mok

  134. Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients

    Article • Rheumatology, September 1997, Oxford University Press (OUP)

    Dr chi chiu mok

  135. Nocardiosis in systemic lupus erythematosus

    Article • Seminars in Arthritis and Rheumatism, February 1997, Elsevier

    Dr chi chiu mok

  136. PRIMARY NOCARDIAL MENINGITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS

    Article • Rheumatology, January 1995, Oxford University Press (OUP)

    Dr chi chiu mok

  137. Systemic lupus

    Article • Springer Science + Business Media

    Dr chi chiu mok

  138. Gender, sex hormones and systemic lupus erythematosus

    Article • The University of Hong Kong Libraries

    Dr chi chiu mok